Delivery Order SPE2DX22D0020-SPE2D824F09VS
- Not listed
- This federal contract award, SPE2DX22D0020|SPE2D824F20BM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $696,995.27 firm fixed-price delivery order contract has an ultimate completion date of February 28, 2024. The contract is not set aside and allows Amerisourcebergen Drug Corp to supply a wide range of pharmaceutical products and medical supplies, including medications across multiple...
- This federal contract award, SPE2DX22D0020|SPE2D825F24QQ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,892.73 delivery order contract is for the provision of various pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain management pharmaceuticals, hormone treatments, and...
- This federal contract award, SPE2DX22D0019|SPE2D825FEZ55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,994.72 firm-fixed-price delivery order is for the provision of various pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and specialized medical supplies. The contract is not set-aside and was issued under Amerisourcebergen's...
- This federal contract award, with ID SPE2DX22D0089|SPE2D824F1A14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,689,174.31 firm fixed-price delivery order contract is for the supply of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The contract is not...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $109,867.10 firm fixed-price delivery order contract has an ultimate completion date of July 8, 2025. The award provides for the supply of a range of pharmaceutical products and medical supplies, including medications across therapeutic areas such as diabetes, neurology, pain management, and antibiotics. This...
- This federal contract award, identified as SPE2DX22D0049|SPE2D824FA3EH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $562,632.85 firm fixed-price delivery order is for the supply of various pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The contract is not set aside and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $91,790.34 firm fixed-price delivery order contract is for the provision of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain management pharmaceuticals, hormone treatments, and antibiotics....
- This federal contract award, valued at $1,261,394.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and it has an ultimate completion date of March 24, 2025. The contract provides for the delivery of a wide range of pharmaceutical products and medical supplies, including medications across various therapeutic domains such as diabetes...
- This federal contract award, with ID SPE2DX22D0020|SPE2D824F06GU, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $839,408.95 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, for the provision of various pharmaceutical products and medical supplies. The contract is not designated as a set-aside and allows for the delivery of a wide range of...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,385.92 firm fixed-price delivery order contract has an ultimate completion date of June 12, 2025 and is not set aside for any specific business type. The contract provides for the delivery of a range of pharmaceutical products and medical supplies, including medications across...
- SPE2DX22D0020Indefinite Delivery Contract
- SPE2DX22D0020-SPE2D824F09VSDelivery Order
This federal contract award, SPE2DX22D0020|SPE2D824F09VS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $792,660.92 firm-fixed-price delivery order contract has an ultimate completion date of December 14, 2023. The contract is not set-aside and provides for the delivery of a wide range of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain management pharmaceuticals, hormone treatments, antibiotics, and specialized medical supplies. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs and other government agencies through December 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $792.7k | 12/13/23 |